- Home
- RXO vs RLAY Comparison
RXO vs RLAY Comparison
Compare RXO & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RXO | RLAY |
|---|---|---|
| Founded | 2022 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 4.1B |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RXO | RLAY |
|---|---|---|
| Price | $19.73 | $18.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 10 |
| Target Price | $16.33 | ★ $19.50 |
| AVG Volume (30 Days) | 1.5M | ★ 2.2M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.81 | 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $5,742,000,000.00 | $15,355,000.00 |
| Revenue This Year | $0.49 | N/A |
| Revenue Next Year | $6.90 | $324.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 26.20 | ★ 53.44 |
| 52 Week Low | $10.43 | $3.86 |
| 52 Week High | $29.90 | $21.27 |
Technical Indicators
Market Signals| Indicator | RXO | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 34.87 | 42.88 |
| Support Level | $19.39 | $18.02 |
| Resistance Level | $20.19 | $20.82 |
| Average True Range (ATR) | 1.09 | 0.87 |
| MACD | -0.09 | -0.25 |
| Stochastic Oscillator | 0.36 | 19.03 |
Price Performance
Historical ComparisonAbout RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.